Developing a new HIV vaccine using advanced technology
The Multi-omics Vaccine Evaluation (MOVE) Consortium
This study is working on a new HIV vaccine that aims to help your body build strong defenses against the virus, so you can have better protection against AIDS.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11076767 on NIH RePORTER |
What this research studies
This research focuses on creating an effective HIV vaccine that can induce broadly neutralizing antibodies (bnAbs) to combat the AIDS pandemic. The approach involves using a series of immunogens delivered in a specific sequence to ensure the immune system can respond effectively without allowing the virus to escape. By integrating multi-omics technology, the research aims to enhance the speed and precision of vaccine development, allowing for a more comprehensive evaluation of the immunogens used. Patients may benefit from this innovative approach as it seeks to provide long-lasting immunity against HIV.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for HIV infection or those living with HIV who are seeking new treatment options.
Not a fit: Patients who are not at risk for HIV or those who are already effectively managing their HIV with existing treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking HIV vaccine that offers durable protection against the virus.
How similar studies have performed: Other research has shown promise in using multi-omics approaches for vaccine development, suggesting potential success for this innovative strategy.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Briney, Bryan — Scripps Research Institute, the
- Study coordinator: Briney, Bryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.